This nanohybrid system was designed to enable precise tumor targeting, enhance the production of antitumor cytokines such as IFN-γ, and suppress the immunosuppressive cytokine TGF-β, thereby reshaping the tumor microenvironment. The gene discussed is TGFB1; the disease is neoplasm.